Xenon Discovery Ltd

About us

As new concepts for drug discovery in the post-genomic age continue to be introduced, synthetic organic chemistry continues to be pivotal to the success of these programs. Xenon Discovery is a contract research organization (CRO) specializing in organic synthesis. We specialize in the synthesis of milligrams to kilogram quantities including: In-depth structure-activity relationship (SAR) studies Intermediates for expediting early stage drug discovery Reference metabolites and agents for compound profiling Building blocks for synthetic medicinal chemistry Key intermediates for pharmaceuticals and also for biochemical and bioinformatics applications Outsourcing should be a strategic component of any sponsor's research and development portfolio, instead of an ad hoc decision, based on the factors in 1) cost-risk benefits (internal vs. external), 2) timing, 3) potential CRO's skillset capabilities and business practices. In medicinal chemistry, this strategy allows in-house chemists to focus on the design and assembly of new lead molecules. Virtual biopharmaceutical companies have embraced outsourcing in order to direct maximum start-up funds to reaching proof-of-concept instead of immediate creation of infra-structure.  Click for details>>